Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Peter Kang, MD
CONTACT
Lead
Masonic Cancer Center, University of Minnesota
With
The University of Minnesota holds equity in, and has rights to potential royalties from, Myogenica, the company that has licensed this trial's stem cell therapy from the University. These interests have been reviewed and managed by the University of Minnesota in accordance with its conflict of interest policies.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
